Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Mahendra Sibartie
Global Medical Affairs, Amgen Ltd, United Kingdom
Poster(s):
(197) Using negative control outcomes in trial emulation to assess the comparability of patients initiating proprotein convertase subtilisin/kexin type 9 inhibitor monoclonal antibodies following myocardial infarction
Monday, August 26, 2024
8:00 AM – 6:00 PM
CEST
